Assertio Holdings Inc (ASRT)
1.03
+0.02
(+1.98%)
USD |
NASDAQ |
May 03, 16:00
1.025
0.00 (0.00%)
After-Hours: 20:00
Assertio Holdings Debt to Equity Ratio: 0.2768 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
December 31, 2023 | 0.2768 |
September 30, 2023 | 0.1975 |
June 30, 2023 | 0.1504 |
March 31, 2023 | 0.1541 |
December 31, 2022 | 0.2963 |
September 30, 2022 | 0.5052 |
June 30, 2022 | 0.4765 |
March 31, 2022 | 0.6572 |
December 31, 2021 | 0.7176 |
September 30, 2021 | 0.8122 |
June 30, 2021 | 0.8559 |
March 31, 2021 | 0.7993 |
December 31, 2020 | 1.515 |
September 30, 2020 | 1.162 |
June 30, 2020 | 1.168 |
March 31, 2020 | 0.6886 |
December 31, 2019 | 6.061 |
September 30, 2019 | 1.472 |
June 30, 2019 | 2.508 |
March 31, 2019 | 2.609 |
December 31, 2018 | 2.569 |
September 30, 2018 | 2.416 |
June 30, 2018 | 3.034 |
March 31, 2018 | 3.067 |
December 31, 2017 | 3.697 |
Date | Value |
---|---|
September 30, 2017 | 3.194 |
June 30, 2017 | 2.978 |
March 31, 2017 | 3.142 |
December 31, 2016 | 2.866 |
September 30, 2016 | 2.456 |
June 30, 2016 | 2.389 |
March 31, 2016 | 2.684 |
December 31, 2015 | 2.540 |
September 30, 2015 | 2.349 |
June 30, 2015 | 2.308 |
March 31, 2015 | 0.6473 |
December 31, 2014 | 0.6308 |
September 30, 2014 | 0.8607 |
June 30, 2014 | 0.00 |
March 31, 2014 | 0.00 |
December 31, 2013 | 0.00 |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.00 |
December 31, 2012 | 0.00 |
September 30, 2012 | 0.00 |
June 30, 2012 | 0.00 |
March 31, 2012 | 0.00 |
December 31, 2011 | 0.00 |
September 30, 2011 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.1504
Minimum
Jun 2023
6.061
Maximum
Dec 2019
1.078
Average
0.7176
Median
Dec 2021
Debt to Equity Ratio Benchmarks
Ocular Therapeutix Inc | 0.8222 |
Cormedix Inc | -- |
Verastem Inc | -- |
Puma Biotechnology Inc | 1.865 |
CytomX Therapeutics Inc | 0.00 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 286.42M |
Total Liabilities (Quarterly) | 148.42M |
Shareholders Equity (Quarterly) | 138.00M |
Current Ratio | 1.831 |
Net Debt Paydown Yield | 5.91% |